Product Information
PITAVASTATIN 4 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $1.2721 per EA under NDC 65862081490. Its NADAC has been published 123 times since Feb 21, 2024.
Strength
4 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862081490
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PITAVASTATIN CALCIUMApproval Type
Generic (ANDA)
FDA Application
ANDA206015On Market Since
11/2/2023
Pharmacological Classes
Price Statistics
The NADAC for PITAVASTATIN 4 MG TABLET has been published 123 times since Feb 21, 2024, and over the history we have for it it has declined 45.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2721 per EA |
|---|---|
| All-time high | $2.3451 (Mar 13, 2024) |
| All-time low | $1.2721 (Jun 17, 2026) |
| 52-week high | $1.5488 |
| 52-week low | $1.2721 |
| Median price | $1.5951 |
| Average price | $1.6430 |
| Largest weekly change | +24.9% (Aug 21, 2024) |
| Weeks tracked | 123 |
| Tracking since | Feb 21, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PITAVASTATIN 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PITAVASTATIN 4 MG TABLET, manufactured by Aurobindo Pharma Limited, is $1.2721 per EA (NDC 65862081490), effective Jun 24, 2026.
How has the price of PITAVASTATIN 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for PITAVASTATIN 4 MG TABLET has declined 45.8%. It has been tracked across 123 weekly CMS publications since Feb 21, 2024.
What are the highest and lowest recorded NADAC prices for PITAVASTATIN 4 MG TABLET?
Since Feb 21, 2024, the NADAC for PITAVASTATIN 4 MG TABLET has ranged from a low of $1.2721 (Jun 17, 2026) to a high of $2.3451 (Mar 13, 2024), with a median of $1.5951 per EA.
Are there cheaper alternatives to PITAVASTATIN 4 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as PITAVASTATIN 4 MG TABLET, but none are currently priced below it.
Who manufactures PITAVASTATIN 4 MG TABLET?
PITAVASTATIN 4 MG TABLET (NDC 65862081490) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification